FerGene Company
FerGene is a newly established company that emerged as a spin-off from Ferring Pharmaceuticals. Its main purpose is to develop and market the gene therapy called nadofaragne firadenovec in the United States and to further its clinical development worldwide.
Funding Status:
Private Equity
Headquarters:
Saint-prex, Vaud
Technology:
Neurological Disorders
Estimated Revenue:
$1M to $10M
Founded Date:
2019
Industry:
Gene Therapy